Southern Healthcare Services LLC
Southern Healthcare Services LLC was paid $6K by Medicaid between Dec 2023 and Sep 2024, across 23 billing codes. Its largest line is 87481, — 19% of everything it billed.
33Billing provider infoSOUTHERN HEALTHCARE SERVICES LLC
HOUSTON, TX 77074
HOUSTON, TX 77074
33aNPI1265017743assigned 03/16/2021
33bProvider typePhlebotomy Technician
28Total paid$6K
24GClaims2,981
24DCodes billed23
24AFirst – last monthDec 2023 – Sep 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 117 | $0.00 | |
| 2024incomplete | 2,864 | $6K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87481 | 19% | 161 | 152 | $1K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 14% | 339 | 251 | $857.85 |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 11% | 59 | 54 | $631.38 |
| 87631 | 8.8% | 116 | 112 | $526.25 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 6.2% | 300 | 247 | $372.95 |
| 87500 | 6.2% | 297 | 245 | $372.95 | |
| 87641 | 6.2% | 296 | 245 | $372.95 | |
| 87653 | 6.2% | 300 | 247 | $372.95 | |
| 87640 | 4.8% | 300 | 247 | $285.98 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.2% | 93 | 87 | $250.56 |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 2.6% | 21 | 20 | $158.59 |
| 87581 | 2.4% | 116 | 112 | $144.46 |
11 more codes
| 87486 | 2.4% | 116 | $144.46 | |
| 87498 | 2.4% | 116 | $144.46 | |
| 87541 | 2.4% | 115 | $144.46 | |
| 80061 | Lipid panel | <1% | 41 | $42.76 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 26 | $15.50 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 43 | $12.40 |
| 80053 | Comprehensive metabolic panel | <1% | 46 | $8.43 |
| 84439 | <1% | 15 | $7.20 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 34 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 17 | $0.00 |
| 81003 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRIZVI, SYED (OWNER)
| Provider | Location | Paid |
|---|---|---|
| DR. Syed S.Rizvi DDS. a Professional Corporation | Stockton, CA | $6.72M |
| Valley Ob/Gyn Medical Group,inc. | Hemet, CA | $5.75M |
| Syed M Rizvi MD LLC | Media, PA | $91K |
| Remedial Medical Services INC | Riverside, CA | $75K |
| Medical Health Lab INC | Sugar Land, TX | $48K |
| Empower Medical Group INC | Orange, CA | $48K |
| Pulmonary Sleep and Critical Care Specialists of North Texas, PA | Decatur, TX | $24K |
| S M Hammad Rizvi M D INC | Upland, CA | $18K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.